KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt issuances
Ratios

Abbott Laboratories (ABT) Long-Term Debt Issuances (2018 - 2025)

Historic Long-Term Debt Issuances for Abbott Laboratories (ABT) over the last 10 years, with Q2 2025 value amounting to $2.0 million.

  • Abbott Laboratories' Long-Term Debt Issuances fell 9909.5% to $2.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 9820.63%. This contributed to the annual value of $223.0 million for FY2024, which is 1105000.0% up from last year.
  • Latest data reveals that Abbott Laboratories reported Long-Term Debt Issuances of $2.0 million as of Q2 2025, which was down 9909.5% from $1.0 million recorded in Q1 2025.
  • Abbott Laboratories' Long-Term Debt Issuances' 5-year high stood at $221.0 million during Q2 2024, with a 5-year trough of $1.0 million in Q3 2022.
  • Moreover, its 5-year median value for Long-Term Debt Issuances was $1.0 million (2022), whereas its average is $29.0 million.
  • In the last 5 years, Abbott Laboratories' Long-Term Debt Issuances surged by 30000.0% in 2021 and then crashed by 9909.5% in 2025.
  • Over the past 5 years, Abbott Laboratories' Long-Term Debt Issuances (Quarter) stood at $4.0 million in 2021, then crashed by 75.0% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then surged by 100.0% to $2.0 million in 2025.
  • Its Long-Term Debt Issuances was $2.0 million in Q2 2025, compared to $1.0 million in Q1 2025 and $1.0 million in Q4 2024.